- Hansa Biopharma: increase in number of shares and votes
- Hansa Biopharma interim report January-March 2024
- Hansa Biopharma Expects Strong First Quarter 2024 Sales Performance
- Hansa Biopharma publishes 2023 Annual and Sustainability Reports
- Evan Ballantyne to join Hansa Biopharma as Chief Financial Officer
More ▼
Key statistics
On Friday, Hansa Biopharma AB (HNSA:STO) closed at 31.94, 58.59% above the 52 week low of 20.14 set on Oct 16, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 30.62 |
---|---|
High | 32.02 |
Low | 30.22 |
Bid | 31.94 |
Offer | 31.94 |
Previous close | 30.62 |
Average volume | 163.75k |
---|---|
Shares outstanding | 63.15m |
Free float | 59.05m |
P/E (TTM) | -- |
Market cap | 1.93bn SEK |
EPS (TTM) | -16.07 SEK |
Data delayed at least 15 minutes, as of May 10 2024 17:00 BST.
More ▼